Skip to Content

Idefirix 11 mg powder for concentrate for solution for infusion

Licence status
Authorised: 25/08/2020
Active substances
Imlifidase
Dosage Form
Powder for concentrate for solution for infusion
Licence number
EU/1/20/1471/001-002
Licence holder
Hansa Biopharma AB

Licence information

ATC code
L04AA Selective immunosuppressants, L04AA41 imlifidase
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
25/08/2020